PharmGKB summary: very important pharmacogene information for CYP2B6.
作者信息
Thorn Caroline F, Lamba Jatinder K, Lamba Vishal, Klein Teri E, Altman Russ B
机构信息
Department of Genetics, Stanford University Medical Center, Stanford, California 94305-5120, USA.
出版信息
Pharmacogenet Genomics. 2010 Aug;20(8):520-3. doi: 10.1097/fpc.0b013e32833947c2.
Abstract
摘要
相似文献
1
PharmGKB summary: very important pharmacogene information for CYP2B6.药物基因组知识库总结：CYP2B6的非常重要的药物基因信息。
Pharmacogenet Genomics. 2010 Aug;20(8):520-3. doi: 10.1097/fpc.0b013e32833947c2.
2
Absence of CYP2B6 promoter -82T>C mutation in Chinese as an additional factor for slow metabolism of drugs commonly used in infections.
Eur J Clin Pharmacol. 2006 Jul;62(7):585-6. doi: 10.1007/s00228-006-0163-6. Epub 2006 Jun 13.
3
PCR-based haplotype determination to distinguish CYP2B6*1/*7 and *5/*6.基于聚合酶链反应的单倍型测定以区分CYP2B6*1/*7和*5/*6。
Clin Chem. 2004 Aug;50(8):1472-3. doi: 10.1373/clinchem.2004.033233.
4
Detection of single nucleotide polymorphisms in CYP2B6 gene.细胞色素P450 2B6基因单核苷酸多态性的检测
Methods Enzymol. 2002;357:45-53. doi: 10.1016/s0076-6879(02)57664-3.
5
Pharmacogenetic screening: HLA-B(*) 5701 vs. CYP2B6 G516T.药物遗传学筛查：HLA - B(*)5701与CYP2B6 G516T
HIV Med. 2011 Apr;12(4):255-6. doi: 10.1111/j.1468-1293.2010.00870.x.
6
CYP2B6: inching towards personalized medicine.细胞色素P450 2B6：向个性化医疗迈进
J Postgrad Med. 2012 Oct-Dec;58(4):233-4. doi: 10.4103/0022-3859.105436.
7
Optimizing efavirenz treatment: CYP2B6 genotyping or therapeutic drug monitoring?优化依非韦伦治疗：CYP2B6基因分型还是治疗药物监测？
Eur J Clin Pharmacol. 2008 Apr;64(4):335-6. doi: 10.1007/s00228-007-0440-z. Epub 2008 Jan 11.
8
Gene-gene interactions between CYP2B6 and CYP2A6 in nicotine metabolism.细胞色素P450 2B6（CYP2B6）与细胞色素P450 2A6（CYP2A6）在尼古丁代谢中的基因-基因相互作用
Pharmacogenet Genomics. 2007 Dec;17(12):1007-15. doi: 10.1097/01.fpc.0000220560.59972.33.
9
PharmGKB summary: very important pharmacogene information for cytochrome P450, family 2, subfamily C, polypeptide 8.药物基因组知识库摘要：细胞色素P450 2C8的非常重要的药物基因信息。
Pharmacogenet Genomics. 2013 Dec;23(12):721-8. doi: 10.1097/FPC.0b013e3283653b27.
10
Pharmacogenetic determinants of interindividual variability in bupropion hydroxylation by cytochrome P450 2B6 in human liver microsomes.细胞色素P450 2B6在人肝微粒体中对安非他酮羟基化的个体间差异的药物遗传学决定因素。
Pharmacogenetics. 2004 Apr;14(4):225-38. doi: 10.1097/00008571-200404000-00002.
引用本文的文献
1
CYP2B6 genetic variation in cyclophosphamide metabolism and hemorrhagic cystitis in Fanconi anemia patients undergoing allogeneic hematopoietic cell transplantation: A descriptive genetic association study.接受异基因造血细胞移植的范可尼贫血患者中，CYP2B6基因变异与环磷酰胺代谢及出血性膀胱炎的关系：一项描述性基因关联研究。
Medicine (Baltimore). 2025 Mar 21;104(12):e41937. doi: 10.1097/MD.0000000000041937.
2
Association between the CYP2B6 polymorphisms and nonnucleoside reverse transcriptase inhibitors drug-induced liver injury: a systematic review and meta-analysis.CYP2B6 多态性与非核苷类逆转录酶抑制剂药物性肝损伤的关联：系统评价和荟萃分析。
Sci Rep. 2024 Nov 27;14(1):29511. doi: 10.1038/s41598-024-79965-0.
3
Opioid use disorder in pediatric populations: considerations for perioperative pain management and precision opioid analgesia.儿科人群中的阿片类药物使用障碍：围手术期疼痛管理和精准阿片类药物镇痛的考虑因素。
Expert Rev Clin Pharmacol. 2024 May-Jun;17(5-6):455-465. doi: 10.1080/17512433.2024.2343915. Epub 2024 Apr 21.
4
Association between gene polymorphisms in the cyclophosphamide metabolism pathway with complications after haploidentical hematopoietic stem cell transplantation.环磷酰胺代谢途径中基因多态性与单倍体造血干细胞移植后并发症的关系。
Front Immunol. 2022 Sep 23;13:1002959. doi: 10.3389/fimmu.2022.1002959. eCollection 2022.
5
Pharmacogenomics of Opioid Treatment for Pain Management.阿片类药物治疗疼痛管理的药物基因组学。
Methods Mol Biol. 2022;2547:491-504. doi: 10.1007/978-1-0716-2573-6_17.
6
Constitutive androstane receptor and pregnane X receptor genotype influence efavirenz plasma concentration and CYP2B6 enzyme activity.组成型雄烷受体和妊娠相关 X 受体基因型影响依非韦伦血药浓度和 CYP2B6 酶活性。
Sci Rep. 2022 Jun 11;12(1):9698. doi: 10.1038/s41598-022-14032-0.
7
Impact of the novel CYP2C:TG haplotype and CYP2B6 variants on sertraline exposure in a large patient population.新型 CYP2C:TG 单倍型和 CYP2B6 变异对大量患者人群中舍曲林暴露的影响。
Clin Transl Sci. 2022 Sep;15(9):2135-2145. doi: 10.1111/cts.13347. Epub 2022 Jun 22.
8
Pharmacogenetic distinction of the Croatian population from the European average.克罗地亚人群与欧洲平均人群的药物遗传学差异。
Croat Med J. 2022 Apr 30;63(2):117-125. doi: 10.3325/cmj.2022.63.117.
9
CYP2B6 Functional Variability in Drug Metabolism and Exposure Across Populations-Implication for Drug Safety, Dosing, and Individualized Therapy.CYP2B6在不同人群药物代谢和暴露中的功能变异性——对药物安全性、给药剂量及个体化治疗的意义
Front Genet. 2021 Jul 12;12:692234. doi: 10.3389/fgene.2021.692234. eCollection 2021.
10
Novel associations between polymorphisms, perioperative methadone metabolism and clinical outcomes in children.新型多态性与围手术期美沙酮代谢和儿童临床结局的关联。
Pharmacogenomics. 2021 Jul;22(10):591-602. doi: 10.2217/pgs-2021-0039. Epub 2021 Jun 8.
本文引用的文献
1
Pharmacokinetics of plasma efavirenz and CYP2B6 polymorphism in southern Chinese.中国南方人群中依非韦伦的药代动力学与 CYP2B6 多态性。
Ther Drug Monit. 2009 Aug;31(4):527-30. doi: 10.1097/FTD.0b013e3181ad74a4.
2
3
Associations between CYP2B6 polymorphisms and pharmacokinetics after a single dose of nevirapine or efavirenz in African americans.非裔美国人单次服用奈韦拉平或依非韦伦后CYP2B6基因多态性与药代动力学之间的关联。
J Infect Dis. 2009 Mar 15;199(6):872-80. doi: 10.1086/597125.
4
Polymorphisms of drug-metabolizing enzymes (GST, CYP2B6 and CYP3A) affect the pharmacokinetics of thiotepa and tepa.药物代谢酶（谷胱甘肽S-转移酶、细胞色素P450 2B6和细胞色素P450 3A）的多态性会影响噻替派和替派的药代动力学。
Br J Clin Pharmacol. 2009 Jan;67(1):50-60. doi: 10.1111/j.1365-2125.2008.03321.x. Epub 2008 Nov 17.
5
Association of drug metabolism gene polymorphisms with toxicities, graft-versus-host disease and survival after HLA-identical sibling hematopoietic stem cell transplantation for patients with leukemia.白血病患者接受人类白细胞抗原（HLA）相合同胞造血干细胞移植后，药物代谢基因多态性与毒性、移植物抗宿主病及生存情况的相关性
Leukemia. 2009 Mar;23(3):545-56. doi: 10.1038/leu.2008.323. Epub 2008 Nov 13.
6
7
CYP2B6: new insights into a historically overlooked cytochrome P450 isozyme.细胞色素P450 2B6：对一种长期被忽视的细胞色素P450同工酶的新见解
Curr Drug Metab. 2008 Sep;9(7):598-610. doi: 10.2174/138920008785821710.
8
Functional pharmacogenetics/genomics of human cytochromes P450 involved in drug biotransformation.参与药物生物转化的人类细胞色素P450的功能药物遗传学/基因组学
Anal Bioanal Chem. 2008 Nov;392(6):1093-108. doi: 10.1007/s00216-008-2291-6. Epub 2008 Aug 10.
9
Impact of CYP2B6 983T>C polymorphism on non-nucleoside reverse transcriptase inhibitor plasma concentrations in HIV-infected patients.CYP2B6基因983T>C多态性对HIV感染患者非核苷类逆转录酶抑制剂血浆浓度的影响。
J Antimicrob Chemother. 2008 Apr;61(4):914-8. doi: 10.1093/jac/dkn029. Epub 2008 Feb 14.
10
Aberrant splicing caused by single nucleotide polymorphism c.516G>T [Q172H], a marker of CYP2B6*6, is responsible for decreased expression and activity of CYP2B6 in liver.由单核苷酸多态性c.516G>T [Q172H]（CYP2B6*6的一个标志物）引起的异常剪接，是肝脏中CYP2B6表达和活性降低的原因。
J Pharmacol Exp Ther. 2008 Apr;325(1):284-92. doi: 10.1124/jpet.107.133306. Epub 2008 Jan 2.
Zotero 插件